In this episode, Pr. Daniela Cesselli (University of Udine) discusses the strategic needs that drove the adoption of a CGP panel and the reasons behind choosing the ๐ข๐ป๐ฐ๐ผ๐๐๐๐ฃยฎ ๐๐ถ๐ solution. Was it to ensure timely results while covering HRD, TM, and MSI testing? To leverage an optimized workflow that enables labs to sequence more samples within the same timeframe? Or perhaps for its responsive support, which operates like a true “guardian angel”?
Webinar
Webinar: Unlocking Precision Oncology: How OncoDNA and MGI provide CGP accessible for cancer patient
Every cancer patient deserves access to the best possible treatment. By combining OncoDNAโs OncoDEEPยฎ DNA Kit with MGIโs DNBSEQโข Platform, we are making comprehensive tumor profiling more affordable and widely available. This powerful combination provides...
